NASDAQ
BioNexus Gene Lab Corp. (BGLC) has a market cap of $4.85M as of Friday, May 22, 2026. The BGLC market cap is up 15.67% over the past 30 days and has declined 4.55% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.